Defective Amplifying Pathway of β-Cell Secretory Response to Glucose in Type 2 Diabetes: Integrated Modeling of In Vitro and In Vivo Evidence

Published on Dec 11, 2017in Diabetes7.72
· DOI :10.2337/DB17-1039
Eleonora Grespan4
Estimated H-index: 4
(National Research Council),
Toni Giorgino20
Estimated H-index: 20
(National Research Council)
+ 3 AuthorsAndrea Mari67
Estimated H-index: 67
(National Research Council)
In vivo studies have investigated the role of β-cell dysfunction in type 2 diabetes (T2D), whereas in vitro research on islets has elucidated key mechanisms that control the insulin secretion rate. However, the relevance of the cellular mechanisms identified in vitro (i.e., the triggering and amplifying pathways) has not been established in vivo. Furthermore, the mechanisms underpinning β-cell dysfunction in T2D remain undetermined. We propose a unifying explanation of several characteristic features of insulin secretion both in vitro and in vivo by using a mathematical model. The model describes the triggering and amplifying pathways and reproduces a variety of in vitro and in vivo tests in subjects with and without T2D, identifies the mechanisms modulating first-phase insulin secretion rate in response to basal hyperglycemia or insulin resistance, and shows that β-cell dysfunction in T2D can be explained by an impaired amplifying pathway with no need to postulate defects in intracellular calcium handling.
📖 Papers frequently viewed together
48 Citations
31 Citations
23 Citations
#1Jean-Claude Henquin (Catholic University of Leuven)H-Index: 84
#2Denis Dufrane (Catholic University of Leuven)H-Index: 27
Last. Myriam Nenquin (Catholic University of Leuven)H-Index: 32
view all 5 authors...
Aims To understand better the control of insulin secretion by human β cells and to identify similarities to and differences from rodent models. Methods Dynamic insulin secretion was measured in perifused human islets treated with pharmacological agents of known modes of action. Results Glucokinase activation (Ro28-1675) lowered the glucose threshold for stimulation of insulin secretion to 1 mmol/L (G1), augmented the response to G3-G5 but not to G8-G15, whereas tolbutamide remained active in G20...
23 CitationsSource
#1Marta Seghieri (UniPi: University of Pisa)H-Index: 6
#2Eleni Rebelos (UniPi: University of Pisa)H-Index: 11
Last. Ele FerranniniH-Index: 110
view all 6 authors...
Restoring euglycaemia for weeks or months improves insulin secretion in patients with type 2 diabetes (T2D). We tested whether mild decrements in fasting glucose (FPG) acutely affect β-cell functio...
4 CitationsSource
#1Jean-Claude Henquin (Catholic University of Leuven)H-Index: 84
#2Denis Dufrane (Catholic University of Leuven)H-Index: 27
Last. Myriam Nenquin (Catholic University of Leuven)H-Index: 32
view all 4 authors...
The biphasic pattern of glucose-induced insulin secretion is altered in type 2 diabetes. Impairment of the first phase is an early sign of β-cell dysfunction, but the underlying mechanisms are still unknown. Their identification through in vitro comparisons of islets from diabetic and control subjects requires characterization and quantification of the dynamics of insulin secretion by normal islets. When perifused normal human islets were stimulated with 15 mmol/l glucose (G15), the proinsulin/i...
51 CitationsSource
#1Mourad Ferdaoussi (U of A: University of Alberta)H-Index: 11
#2Xiaoqing Dai (U of A: University of Alberta)H-Index: 11
Last. Patrick E. MacDonald (U of A: University of Alberta)H-Index: 48
view all 30 authors...
Insulin secretion from β cells of the pancreatic islets of Langerhans controls metabolic homeostasis and is impaired in individuals with type 2 diabetes (T2D). Increases in blood glucose trigger insulin release by closing ATP-sensitive K+ channels, depolarizing β cells, and opening voltage-dependent Ca2+ channels to elicit insulin exocytosis. However, one or more additional pathway(s) amplify the secretory response, likely at the distal exocytotic site. The mitochondrial export of isocitrate and...
98 CitationsSource
#1Jaber DehghanyH-Index: 6
#2Peter Hoboth (MPG: Max Planck Society)H-Index: 4
Last. Michael Meyer-Hermann (Braunschweig University of Technology)H-Index: 36
view all 8 authors...
Insulin secretion from pancreatic β-cells in response to sudden glucose stimulation is biphasic. Prolonged secretion in vivo requires synthesis, delivery to the plasma membrane (PM) and exocytosis of insulin secretory granules (SGs). Here, we provide the first agent-based space-resolved model for SG dynamics in pancreatic β-cells. Using recent experimental data, we consider a single β-cell with identical SGs moving on a phenomenologically represented cytoskeleton network. A single exocytotic mac...
11 CitationsSource
#1Sara F. Michaliszyn (University of Pittsburgh)H-Index: 15
#2Andrea MariH-Index: 67
Last. Silva A. Arslanian (University of Pittsburgh)H-Index: 82
view all 8 authors...
Using the hyperglycemic and euglycemic clamp, we demonstrated impaired β-cell function in obese youth with increasing dysglycemia. Herein we describe oral glucose tolerance test (OGTT)-modeled β-cell function and incretin effect in obese adolescents spanning the range of glucose tolerance. β-Cell function parameters were derived from established mathematical models yielding β-cell glucose sensitivity (βCGS), rate sensitivity, and insulin sensitivity in 255 obese adolescents (173 with normal gluc...
50 CitationsSource
#1Patrick Gilon (UCL: Université catholique de Louvain)H-Index: 52
#2Heeyoung Chae (UCL: Université catholique de Louvain)H-Index: 6
Last. Magalie A. Ravier (French Institute of Health and Medical Research)H-Index: 28
view all 4 authors...
Changes in cytosolic free Ca(2+) concentration ([Ca(2+)]c) play a crucial role in the control of insulin secretion from the electrically excitable pancreatic β-cell. Secretion is controlled by the finely tuned balance between Ca(2+) influx (mainly through voltage-dependent Ca(2+) channels, but also through voltage-independent Ca(2+) channels like store-operated channels) and efflux pathways. Changes in [Ca(2+)]c directly affect [Ca(2+)] in various organelles including the endoplasmic reticulum (...
116 CitationsSource
#1Andrea Mari (National Research Council)H-Index: 67
#2Jonatan I. Bagger (UCPH: University of Copenhagen)H-Index: 17
Last. Tina Vilsbøll (UCPH: University of Copenhagen)H-Index: 60
view all 6 authors...
The incretin effect on insulin secretion was investigated in 8 subjects with type 2 diabetes (T2D) and 8 with normal glucose tolerance (NGT), using 25, 75, and 125 g oral glucose tolerance tests (OGTT) and isoglycemic intravenous glucose infusions (IIGI). The s-cell response was evaluated using a model embedding a dose-response (slope = glucose sensitivity), an early response (rate sensitivity), and potentiation (time-related secretion increase). The incretin effect, as OGTT/IIGI ratio, was calc...
30 CitationsSource
#1Marc Prentki (UdeM: Université de Montréal)H-Index: 88
#2Franz M. Matschinsky (UPenn: University of Pennsylvania)H-Index: 76
Last. S.R. Murthy Madiraju (UdeM: Université de Montréal)H-Index: 24
view all 3 authors...
The pancreatic islet β cell senses circulating levels of calorigenic nutrients to secrete insulin according to the needs of the organism. Altered insulin secretion is linked to various disorders such as diabetes, hypoglycemic states, and cardiometabolic diseases. Fuel stimuli, including glucose, free fatty acids, and amino acids, promote insulin granule exocytosis primarily via their metabolism in β cells and the production of key signaling metabolites. This paper reviews our current knowledge o...
326 CitationsSource
#1Patrik Rorsman (University of Oxford)H-Index: 107
#2Matthias BraunH-Index: 31
Pancreatic β cells secrete insulin, the body's only hormone capable of lowering plasma glucose levels. Impaired or insufficient insulin secretion results in diabetes mellitus. The β cell is electrically excitable; in response to an elevation of glucose, it depolarizes and starts generating action potentials. The electrophysiology of mouse β cells and the cell's role in insulin secretion have been extensively investigated. More recently, similar studies have been performed on human β cells. These...
380 CitationsSource
Cited By16
#1Ruth L. M. Cordiner (Dund.: University of Dundee)H-Index: 1
#2Andrea Mari (National Research Council)H-Index: 67
Last. Ewan R. Pearson (Dund.: University of Dundee)H-Index: 58
view all 4 authors...
AIMS/HYPOTHESIS Studies in permanent neonatal diabetes suggest that sulphonylureas lower blood glucose without causing hypoglycaemia, in part by augmenting the incretin effect. This mechanism has not previously been attributed to sulphonylureas in patients with type 2 diabetes (T2DM). We therefore aimed to evaluate the impact of low dose gliclazide on beta-cell function and incretin action in patients with T2DM. METHODS Paired oral glucose tolerance tests and isoglycaemic infusions were performe...
#5Uwe Panten (Braunschweig University of Technology)H-Index: 8
The pancreatic beta-cell transduces the availability of nutrients into the secretion of insulin. While this process is extensively modified by hormones and neurotransmitters, it is the availability of nutrients, above all glucose, which sets the process of insulin synthesis and secretion in motion. The central role of the mitochondria in this process was identified decades ago, but how changes in mitochondrial activity are coupled to the exocytosis of insulin granules is still incompletely under...
1 CitationsSource
#1Jean-Claude Henquin (Catholic University of Leuven)H-Index: 84
Abstract Background Diabetes always involves variable degrees of β-cell demise and malfunction leading to insufficient insulin secretion. Besides clinical investigations, many research projects used rodent islets to study various facets of β-cell pathophysiology. Their important contributions laid the foundations of steadily increasing numbers of experimental studies resorting to isolated human islets. Scope of review This review, based on an analysis of data published over 60 years of clinical ...
4 CitationsSource
#1Ele Ferrannini (National Research Council)H-Index: 14
#1Ele Ferrannini (National Research Council)H-Index: 110
Insulin resistance and β-cell dysfunction are the core pathophysiological mechanisms of all hyperglycemic syndromes. Advances in in vivo investigative techniques have made it possible to quantify insulin resistance in multiple sites (skeletal and myocardial muscle, subcutaneous and visceral fat depots, liver, kidney, vascular tissues, brain and intestine), to clarify its consequences for tissue substrate selection, and to establish its relation to tissue perfusion. Physiological modeling of β-ce...
1 CitationsSource
#1Eleonora Grespan (National Research Council)H-Index: 4
#2Toni Giorgino (University of Milan)H-Index: 3
Last. Andrea Mari (National Research Council)H-Index: 67
view all 5 authors...
Abstract Background and aims. The reduced action of incretin hormones in type 2 diabetes (T2D) is mainly attributed to GIP insensitivity, but efficacy estimates of GIP and GLP-1 differ among studies, and the negligible effects of pharmacological GIP doses remain unexplained. We aimed to characterize incretin action in vivo in subjects with normal glucose tolerance (NGT) or T2D and provide an explanation for the different insulinotropic activity of GIP and GLP-1 in T2D subjects. Methods We used i...
3 CitationsSource
#1Vladimir GrubelnikH-Index: 8
#2Jan ZmazekH-Index: 2
Last. Marko MarhlH-Index: 30
view all 5 authors...
Type 2 diabetes mellitus is a complex multifactorial disease of epidemic proportions. It involves genetic and lifestyle factors that lead to dysregulations in hormone secretion and metabolic homeostasis. Accumulating evidence indicates that altered mitochondrial structure, function, and particularly bioenergetics of cells in different tissues have a central role in the pathogenesis of type 2 diabetes mellitus. In the present study, we explore how mitochondrial dysfunction impairs the coupling be...
4 CitationsSource
#1Andrea Mari (National Research Council)H-Index: 67
#2Andrea Tura (National Research Council)H-Index: 35
Last. Roberto Bizzotto (National Research Council)H-Index: 7
view all 4 authors...
Mathematical modeling in the field of glucose metabolism has a longstanding tradition. The use of models is motivated by several reasons. Models have been used for calculating parameters of physiological interest from experimental data indirectly, to provide an unambiguous quantitative representation of pathophysiological mechanisms, to determine indices of clinical usefulness from simple experimental tests. With the growing societal impact of type 2 diabetes, which involves the disturbance of t...
#1Joon Ha (NIH: National Institutes of Health)H-Index: 10
#2Arthur Sherman (NIH: National Institutes of Health)H-Index: 52
Diabetes is a chronic, progressive disease that calls for longitudinal data and analysis. We introduce a longitudinal mathematical model that is capable of representing the metabolic state of an individual at any point in time during their progression from normal glucose tolerance to type 2 diabetes (T2D) over a period of years. As an application of the model, we account for the diversity of pathways typically followed, focusing on two extreme alternatives, one that goes through impaired fasting...
4 CitationsSource
#1Mourad Ferdaoussi (U of A: University of Alberta)H-Index: 11
#2Nancy Smith (U of A: University of Alberta)H-Index: 6
Last. Patrick E. MacDonald (U of A: University of Alberta)H-Index: 48
view all 9 authors...
Pancreatic islet insulin secretion is amplified by both metabolic and receptor-mediated signaling pathways. The incretin-mimetic and DPPIV inhibitor anti-diabetic drugs increase insulin secretion, but in humans this can be variable both in vitro and in vivo. We examined the correlation of GLP-1 induced insulin secretion from human islets with key donor characteristics, glucose-responsiveness, and the ability of glucose to augment exocytosis in beta-cells. No clear correlation was observed betwee...
4 CitationsSource